Navigation Links
Bion Responds to Confusion over Name and Symbol
Date:7/9/2012

NEW YORK, July 9, 2012 /PRNewswire/ -- Bion Environmental Technologies, Inc. (OTC BB/QB: BNET) addressed today the recent confusion over similarities in name and symbol with BioNitrogen Corporation (Pink Sheets: BION).

Bion Environmental Technologies trades on the OTC Bulletin Board and OTC QB markets under the symbol BNET. Bion is a Colorado corporation (since 1989) with headquarters in New York and is fully-reporting under the Securities and Exchange Act of 1934. The Company has developed a micro-aerobic waste treatment technology that provides the only comprehensive solution to the environmental impacts of livestock production waste while simultaneously recovering valuable assets from the waste stream, including renewable energy and the nutrients phosphorus and nitrogen. 

BioNitrogen Corporation trades on the OTC Pink Sheets under the symbol BION, which has created the confusion. BioNitrogen was incorporated in 2009, more than 20 years after Bion Environmental Technologies began using its name. BioNitrogen does not report under the SEC Act of 1934. According to the Company's website, "BioNitrogen is an American company focused on building fully operational, turnkey manufacturing facilities in the global marketplace to produce urea [nitrogen-based crop fertilizer]." According to the OTC Markets website, BioNitrogen is a development-stage company that recently closed on a financing "to complete the basic engineering design and advance towards the process of building plants and producing urea." The Company's technology is patent-pending.    

In contrast, Bion Environmental Technologies has provided solutions to the livestock industry for 22 years, with 30 of its first-generation systems installed through 2003. The Company held the grand opening of its showcase second-generation system in July 2011 at Kreider Farms, in Lancaster County, PA. The project was financed by the Pennsylvania Infrastructure Investment Authori
'/>"/>

SOURCE Bion Environmental Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Squamous Cell Cancer Responds to SPDT Therapy
2. Oxitec Responds to University of Panamas Forum on Transgenic Mosquitoes
3. Butamax™ Responds to Gevo Patent Infringement Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... LOS ANGELES , May 20, 2013 ... San Francisco , James ... of Clinical Psychiatry at the Semel Institute for Neuroscience ... of Medicine at the University of California ... in both Child and Adolescent Psychopharmacology and ADHD at ...
(Date:5/20/2013)... , May 20, 2013 Pacific Biomarkers and Clinigene ... for developers of biosimilars at the 2013 AAPS/ ... San Diego Hotel and Marina , ... have the opportunity to speak with company representatives at ... That Cross" on May 21 from 1-2 p.m. in ...
(Date:5/20/2013)... HILL, N.C. , May 20, 2013 /PRNewswire/ ... company focused on developing differentiated antibiotics to meet ... infections, today announced that it presented data at ... in Philadelphia demonstrating the ... levofloxacin in Cempra,s prior Phase 2 clinical trial ...
(Date:5/20/2013)... May 20, 2013 Interventional cardiologist Tony ... General Hospital (AGH) Cardiovascular Institute have helped pioneer ... artery disease (CAD) over the past three decades, ... balloon angioplasty and coronary artery stent implantation. , Today, ... play a prominent role in the study of a ...
Breaking Biology Technology:Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4
... global provider of enterprise information quality solutions, and ... solutions company based in Connecticut, have verbally agreed not ... 15, concluding Pitney's planned acquisition of Firstlogic. , ,The ... a review of a Second Request for Information issued ...
... Health and Human Services Tommy Thompson has been elected to ... of information systems for high-acuity care areas of a hospital, ... intensive care unit. , ,Thompson began his career in public ... He was elected assistant Assembly minority leader in 1973 and ...
... Wisconsin company specializing in functional Magnetic Resonance Imaging ... the 2005 edition of the Minnies, awarded by ... and related professionals in medical imaging. , ,This ... categories. AuntMinnie.com members voted Neurognostics one of the ...
Cached Biology Technology:
(Date:5/20/2013)... effect of physical education (PE) on child weight, but ... the amount of time that elementary schoolchildren spent in ... study represents some of the first evidence of a ... forthcoming in the Journal of Health Economics . ... be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The research ...
(Date:5/20/2013)... grant will help establish the Center for Advanced Research ... of Illinois at Urbana-Champaign and Worcester Polytechnic Institute (WPI) ... research in drying moist, porous materials such as food ... products; textiles; and biopharmaceuticals," said Hao Feng, a U ... and the Illinois site director. , According to Feng, ...
(Date:5/20/2013)... Geology articles posted online ahead of print ... swath of geoscience subdisciplines, including minerals exploration, archaeology, ... studied include Siberia; the Sumatran subduction margin; the ... Mars; and the Southeastern U.S. Atlantic Margin. Brief ... plate tectonics;, 2. The clear fingerprint of ice ...
Breaking Biology News(10 mins):Gym class reduces probability of obesity, study finds for first time 2NSF approves planning grant for Center for Advanced Research in Drying 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11
... Ala. The newest generation of compact research freezers ... the scientific capacity of the International Space Station (ISS), ... (UAB). A UAB-designed cryogenic freezer called GLACIER, short ... its NASA debut in late 2008 aboard a shuttle ...
... the latest American Chemical Society (ACS) Weekly ... It has news from ACS, 34 peer-reviewed ... .,Please credit the individual journal or the ... this information. PressPac Archive: http://portal.acs.org/portal/acs/corg/content?_nfpb=true&_pageLabel=PP_ARTICLEMAIN&node_id=223&content_id=CTP_006742&use_sec=true&sec_url_var=region1 ...
... a new approach to prevent bacterial infections from taking ... , Dr Quinn Parks and colleagues describe how they ... cells to prevent Pseudomonas aeruginosa bacteria from ... both the body,s immune mechanisms and antibiotics. When ...
Cached Biology News:American Chemical Society's weekly PressPac -- March 11, 2009 2American Chemical Society's weekly PressPac -- March 11, 2009 3American Chemical Society's weekly PressPac -- March 11, 2009 4American Chemical Society's weekly PressPac -- March 11, 2009 5American Chemical Society's weekly PressPac -- March 11, 2009 6
Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
Biology Products: